The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike subcutaneous injections, this approach offers a simpler way to provide GLP-1 https://arranvzsh035152.pages10.com/glp-1-patches-a-novel-approach-to-blood-sugar-treatment-76376469